Altos Labs vs Tempus
Side-by-side comparison of AI visibility scores, market position, and capabilities
Altos Labs is a longevity biotech company focused on cellular rejuvenation programming to reverse disease and extend healthspan; raised $3B at launch in 2022 backed by Jeff Bezos and Yuri Milner;
About
Altos Labs is a biotechnology company incorporated in 2021 and publicly launched in January 2022 with an extraordinary $3 billion Series A — the largest biotech launch funding round in history. The company is backed by Jeff Bezos and Yuri Milner, among others, and is headquartered in San Carlos, California, with research institutes in Cambridge, UK, and Japan. Altos Labs is focused on biological reprogramming and cellular rejuvenation — the scientific field exploring whether Yamanaka factors (a set of transcription factors that can reset a cell's epigenetic age) can be applied therapeutically to reverse disease progression and restore cellular function in aging tissues without causing cancer or loss of cell identity.
Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.
About
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.